Search for: "Novartis International AG" Results 61 - 80 of 120
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Mar 2015, 4:01 pm
They would mean that libraries can acquire and lend commercially available digital materials and, with archives, can continue to underpin knowledgeable societies in the digital age. [read post]
30 Apr 2019, 5:29 am
  Jürgen Dressel (ex- Novartis Pharma AG) further commented that of course there is the further issue in Germany that invalidity proceedings cannot even be commenced whilst EPO opposition proceeding are ongoing. [read post]
18 Oct 2010, 3:07 am by Marie Louise
SEB S.A (Patently-O) (Inventive Step) (Filewrapper) New false marking bill introduced in the House (Patent Docs) (271 Patent Blog) (FDA Law Blog) UK: Court of Appeal gives guidance on enablement: Novartis AG & Cibavision AG v. [read post]
29 Jun 2011, 3:34 am by Marie Louise
(Patent Docs) Deferacirox – India: Cipla wins pre grant opposition (593/CHENP/2005): Novartis v. [read post]
1 May 2009, 9:00 am
  Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen)… [read post]
17 Nov 2010, 1:48 am by Kelly
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No… [read post]
6 Jan 2022, 1:22 pm by Kevin LaCroix
And there are still similar derivative cases pending against the boards of, among others, Deutsche Bank, Volkswagen, Barclays, and Novartis. [read post]
26 Jun 2013, 6:43 am
It is therefore insufficient: see Novartis AG v Johnson & Johnson Medical Ltd [2010] EWCA Civ 1039, [2011] ECC 10 at [77]. [read post]
28 Apr 2019, 8:20 am
  In the Rituximab case (District Court of Munich, May 2017), the court said that the generic case law stipulating that the balance of interests in principle favors the originator cannot be applied to biosimilar situations and that a full assessment of the specific circumstances is required in each case.From the audience Jürgen Dressel (ex-Novartis Pharma AG, Basel) asked about the uptake of biosimilars and whether costs will decrease the more medicines healthcare systems… [read post]
18 May 2015, 11:01 am
The Court of Justice of the European Union (CJEU) addresses that issue in Dimensione Direct Sales srl and Michele Labianca v Knoll International SpA, C-516/13 -- and so does Eleonora in this post.* "Now Now, mere reputation is not enough for passing-off" says Supreme CourtIn Starbucks (HK) Limited and another v British Sky Broadcasting Group plc and others [2015] UKSC 31, the UK Supreme Court rejected arguments that it should expand its jurisprudence on… [read post]
27 Mar 2022, 7:33 pm by Seth Davis
Two whistleblowers argued that they were eligible for an award in connection with the SEC’s investigation of Novartis AG, a pharmaceutical company, for violations of the Foreign Corrupt Practices Act. [read post]
15 Dec 2014, 7:25 am
*     *     *When Trademarks Overlap With Other IP Rights Special*     *     *"When Trademarks Overlap with Other IP Rights" is the International Trademark Association’s (INTA) European winter conference that took place last week in the lovely city of Munich. [read post]
6 Apr 2019, 9:46 am
AG Szpunar thinks not necessarily | The CNY 260 million fine on QVOD is final! [read post]
27 Mar 2019, 11:33 am
AG Szpunar thinks not necessarily | The CNY 260 million fine on QVOD is final! [read post]
22 Apr 2010, 3:51 am
(Patent Docs) Bystolic (Nebivolol) – Austrian Supreme Court on limitation of patent claims: Case no 17 Ob 24/09t (EPLAW) Denegard / Milbemite / Ocupress - US: District Court W D Tennessee: False marking complaint: Baker v Novartis Pharmaceuticals et al (Patent Docs) Felbatol (Felbamate) – US: CAFC affirms District Court decision enforcing settlement agreement regarding the transfer of patent ownership: MedPointe Healthcare, Inc v Kozachuk (not precedential) (Patent Docs) Husar… [read post]
28 Jul 2010, 12:06 am by Kelly
(Patent Docs) Levitra (Vardenafil) – US: Patent infringement complaint following a Paragraph IV certification: Bayer Schering Pharma AG et al. v. [read post]
19 Mar 2022, 2:09 pm by admin
., that an individual will become ill or die within a stated period of time or by a certain age). [read post]
18 Oct 2010, 1:47 am by Medical Library
An estimated 95% of cases occur in Asia and Africa and up to 60% of cases are in children under 15 years of age. [read post]
31 Jan 2011, 3:19 am by Kelly
Coflexip v Stolt (PatLit) Fuzzy boundaries, woolly limitations and over-broad claims: a case-study in insufficiency: Novartis AG & Cibavision AG v Johnson & Johnson (jiplp) ‘Where there is friendship, there is also fun’: President Bauer speaks to the IPKat (IPKat) PCC Page 13: Snails and Octopuses (PatLit) EWHC (Ch) – Galileo and the case of the ventilating hearing officer: Galileo International Technology LLC v European Union (formerly… [read post]